Acceptance Test Results of ProTom International Inc. Proton Therapy Technology Exceeds Expectations

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

FLINT, Mich.--(BUSINESS WIRE)--Initial acceptance test results of ProTom International, Inc.'s (“ProTom”) Radiance 330® Proton Therapy System (“Radiance 330”) are exceeding the expectations of medical physicists charged with clinical commissioning at the McLaren Proton Therapy Center (“MPTC”) in Flint, Michigan.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC